OAM
MBII

Oxford Asset Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Oxford Asset Management’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,642
Closed -$18K – 2039
2019
Q1 		$18K Sell
11,642
-33,914
-74% -$51.7K ﹤0.01% 1616
2018
Q4 		$67K Buy
+45,556
New +$69.8K ﹤0.01% 1683

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FC
Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

Oxford Asset Management's MBII Position: Q2 2019 in Review

Oxford Asset Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2019, closing a stake of 11,642 shares — an estimated $18K sold.

Oxford Asset Management first reported a position in MBII in Q4 2018 and held it in 2 quarters. The position peaked at $67K in Q4 2018. 49 funds tracked by Wall St. Rank hold MBII as of Q2 2019.

  • Oxford Asset Management reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2019 after selling out during the quarter.
  • Oxford Asset Management sold 11,642 Marrone Bio Innovations, Inc. shares in Q2 2019, an estimated $18K.
  • Oxford Asset Management first reported a position in Marrone Bio Innovations, Inc. in Q4 2018 and held it in 2 quarters.
  • Oxford Asset Management's Marrone Bio Innovations, Inc. position peaked at $67K in Q4 2018.
  • 49 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2019.

Based on Oxford Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.